FIBRINOLYSIS AND FORMATION OF BIOLOGICALLY ACTIVE POLYPEPTIDES.
D000510:Alpha-Globulins; D000614:Aminocaproates; D015119:Aminocaproic Acid; D000707:Anaphylaxis; D000799:Angioedema; D001779:Blood Coagulation Factors; D002276:Carcinoid Tumor; D002493:Central Nervous System Diseases; D004792:Enzyme Precursors; D005174:Factor XII; D005341:Fibrinolysin; D005342:Fibrinolysis; D006801:Humans; D007610:Kallikreins; D007705:Kinins; D010195:Pancreatitis; D010455:Peptides; D012106:Research; D014665:Vasodilator Agents
D000510:Alpha-Globulins; D000614:Aminocaproates; D001779:Blood Coagulation Factors; D004792:Enzyme Precursors; D007705:Kinins; D010455:Peptides; D014665:Vasodilator Agents; D005174:Factor XII; D007610:Kallikreins; D005341:Fibrinolysin; D015119:Aminocaproic Acid
ALPHA GLOBULIN; AMINOCAPROIC ACID; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; BLOOD COAGULATION FACTORS; CARCINOID TUMOR; CENTRAL NERVOUS SYSTEM DISEASES; ENZYME PRECURSORS; EXPERIMENTAL LAB STUDY; FACTOR XII; FIBRINOLYSIN; FIBRINOLYSIS; KALLIKREIN; KININS; PANCREATITIS; PEPTIDES; REVIEW; VASODILATOR AGENTS